2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $91M | $97M | $123M | $43M | $186M |
Cost of Revenue | $72M | $77M | $114M | $36M | $145M |
Gross Profit | $18M | $20M | $9.1M | $7.2M | $41M |
Gross Profit % | 20% | 21% | 7.4% | 17% | 22% |
R&D Expenses | $3.4M | $3.4M | $3.8M | $4.1M | $3.9M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $1.9M | $2.4M | -$8.8M | $367K | $4.6M |
Dep. & Amort. | $2M | $1.9M | $5.6M | $6M | $5.4M |
Def. Tax | -$287K | -$561K | -$3.2M | -$120K | -$472K |
Stock Comp. | $975K | $864K | $809K | $806K | $1.3M |
Chg. in WC | -$4.5M | -$7.6M | $4.3M | $2.9M | $15M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $33M | $60M | $15M | $18M | $17M |
ST Investments | $40M | $5.5M | $0 | $0 | $0 |
Cash & ST Inv. | $73M | $65M | $15M | $18M | $17M |
Receivables | $30M | $37M | $54M | $64M | $72M |
Inventory | $22M | $17M | $17M | $26M | $33M |
Revenue for the quarter was $47 million, a 7.3% increase year-over-year, with gross margin improving by 260 basis points to 24.8% and adjusted EBITDA margin expanding by 180 basis points to 8.6%.
Fiscal 2025 revenue guidance remains at $200-$210 million, with adjusted EBITDA expected between $18-$21 million, reflecting 47% growth at the midpoint. Gross margin guidance was raised to 24%-25%.
Backlog totaled $385 million as of December 31, with 80% from defense and approximately 45%-50% expected to convert within the next 12 months.
Capital expenditures for fiscal 2025 are now expected to be $15-$19 million, up from prior guidance, with major projects including a cryogenic propellant testing facility and defense expansion in Batavia, New York.
The company is actively pursuing M&A opportunities targeting engineered products with strong IP and aftermarket potential, supported by a robust balance sheet with $30 million in cash and no debt.